Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: BACTROBAN

Summary for Tradename: BACTROBAN

Suppliers: see list7
patent expirations by year for

Pharmacology for Tradename: BACTROBAN

Clinical Trials for: BACTROBAN

A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2% and Bactroban® Cream and Compare Both to a Vehicle in Treatment of Secondarily Infected Traumatic Skin Lesions.
Status: Completed Condition: Secondarily Infected Traumatic Skin Lesions

Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection
Status: Completed Condition: Nasal Colonization With Staphylococcus Aureus; HIV Infections

Efficacy Study of Mupirocin on Infection After Coronary Artery Bypass Grafting
Status: Completed Condition: Surgical Site Infections

Prevention of Surgical Site Infections: Effectiveness of Nasal Povidone-Iodine and Nasal Mupirocin
Status: Completed Condition: Surgical Site Infection

Preventing Staphylococcal (Staph) Infection
Status: Completed Condition: Staphylococcal Infections

Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Status: Recruiting Condition: Staphylococcal Infection

Topical Gentamicin Cream Versus Alternating Gentamicin and Mupirocin Cream in Peritoneal Dialysis
Status: Not yet recruiting Condition: Rate of Exit Site Infection; Rate of Atypical Mycobacterial Infection; Rate of Peritoneal Dialysis

Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections
Status: Completed Condition: Cross Infection; Staphylococcal Infections

Impact of Mupirocin Decolonization on the Nasal Microbiome
Status: Recruiting Condition: Nasal Colonization With Staph Aureus

Use of Ointments in Prevention of Catheter Related Infections in PD
Status: Active, not recruiting Condition: Peritoneal Dialysis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
OINTMENT;TOPICAL050591Dec 31, 1987RXYes<disabled><disabled>
mupirocin calcium
CREAM;TOPICAL050746Dec 11, 1997RXYes5,569,672<disabled><disabled>
mupirocin calcium
CREAM;TOPICAL050746Dec 11, 1997RXYes6,025,389<disabled>Y<disabled>
mupirocin calcium
OINTMENT;NASAL050703Sep 18, 1995RXYes5,569,672<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology